• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加速常规初级保健中老年患者机会性心房颤动筛查。

Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care.

机构信息

Local Independent Administrative Institution, Akita Prefectural Hospital Organization, Akita, Japan.

The Japan Stroke Association, Osaka, Japan.

出版信息

PLoS One. 2020 Dec 30;15(12):e0244240. doi: 10.1371/journal.pone.0244240. eCollection 2020.

DOI:10.1371/journal.pone.0244240
PMID:33378380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7773196/
Abstract

Cardio-embolic ischemic stroke caused by atrial fibrillation is more severe compared with other types of stroke, such as lacunar infarction and atherothrombotic infarction in patients without atrial fibrillation. Therefore, it is important to prevent cardio-embolic ischemic stroke by detecting atrial fibrillation early in at-risk patients and administering appropriate anticoagulation therapy. This prospective observational study aimed to evaluate the effectiveness of opportunistic atrial fibrillation screening at 12 primary clinics in Japan. The study included a 12-month pre-campaign period and a 12-month campaign period. During the campaign period, an awareness campaign was conducted to encourage physicians to be mindful of screening patients aged ≥65 years for atrial fibrillation by checking their pulses and performing subsequent electrocardiography when an irregular pulse was detected. The primary outcome was the proportion of patients with newly diagnosed atrial fibrillation. A sub-analysis focusing on first-time outpatients was performed. There were 9921 and 10,282 patients with no history of atrial fibrillation in the pre-campaign and campaign periods, respectively. In the whole population, the proportion of patients with newly diagnosed atrial fibrillation was 0.9% throughout the pre-campaign and campaign periods. In the sub-analysis limited to first-time outpatients, the detection proportion increased from 1.6% to 1.9% during the campaign period. In terms of age stratification, a large increase in detection was observed, especially among patients aged 65-74 years (detection increased from 0.9% to 1.5%) and ≥85 years (detection increased from 2.9% to 3.3%) during the campaign period. Our findings suggest the feasibility of opportunistic atrial fibrillation screening in routine primary care practice in Japan. Of note, our findings suggest that opportunistic atrial fibrillation screening targeting first-time outpatients may be of clinical value.

摘要

心房颤动引起的心源性栓塞性缺血性卒中比其他类型的卒中(如无房颤患者的腔隙性梗死和动脉粥样硬化血栓性梗死)更为严重。因此,通过早期检测高危患者的房颤并给予适当的抗凝治疗,预防心源性栓塞性缺血性卒中非常重要。本前瞻性观察性研究旨在评估在日本 12 家初级诊所进行机会性房颤筛查的效果。该研究包括 12 个月的预活动期和 12 个月的活动期。在活动期间,开展了一项宣传活动,鼓励医生在筛查年龄≥65 岁的患者时注意房颤,检查脉搏,如果发现不规则脉搏,随后进行心电图检查。主要结局是新诊断为房颤的患者比例。进行了一项重点关注首次门诊患者的亚分析。在预活动期和活动期,分别有 9921 例和 10282 例无房颤病史的患者。在整个人群中,预活动期和活动期新诊断房颤患者的比例均为 0.9%。在仅限于首次门诊患者的亚分析中,活动期的检出率从 1.6%增加到 1.9%。在年龄分层方面,检出率有较大增加,尤其是在 65-74 岁(从 0.9%增加到 1.5%)和≥85 岁(从 2.9%增加到 3.3%)的患者中。我们的研究结果表明,在日本的常规初级保健实践中,机会性房颤筛查是可行的。值得注意的是,我们的研究结果表明,针对首次门诊患者的机会性房颤筛查可能具有临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee76/7773196/672cff3648aa/pone.0244240.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee76/7773196/672cff3648aa/pone.0244240.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee76/7773196/672cff3648aa/pone.0244240.g001.jpg

相似文献

1
Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care.加速常规初级保健中老年患者机会性心房颤动筛查。
PLoS One. 2020 Dec 30;15(12):e0244240. doi: 10.1371/journal.pone.0244240. eCollection 2020.
2
Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.在日本常规临床实践中,以患者为中心的抗凝药物管理对心房颤动患者口服抗凝治疗的影响:一项前瞻性、观察性研究。
BMC Cardiovasc Disord. 2019 Oct 24;19(1):235. doi: 10.1186/s12872-019-1216-y.
3
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.一项针对65岁及以上人群检测心房颤动的系统筛查(针对性筛查和全人群筛查)与常规做法的随机对照试验及成本效益研究。SAFE研究。
Health Technol Assess. 2005 Oct;9(40):iii-iv, ix-x, 1-74. doi: 10.3310/hta9400.
4
Effectiveness of systematic screening for the detection of atrial fibrillation.系统性筛查用于检测心房颤动的有效性。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009586. doi: 10.1002/14651858.CD009586.pub2.
5
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.心房颤动的筛查策略:系统评价与成本效益分析
Health Technol Assess. 2017 May;21(29):1-236. doi: 10.3310/hta21290.
6
Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.在一家普通诊所为65岁及以上每年前往流感疫苗接种门诊的患者筛查心房颤动。
Qual Prim Care. 2013;21(2):131-40.
7
Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.机会性筛查与常规护理在初级保健中检测心房颤动的比较:集群随机对照试验。
BMJ. 2020 Sep 16;370:m3208. doi: 10.1136/bmj.m3208.
8
Opportunistic screening for atrial fibrillation versus detecting symptomatic patients aged 65 years and older: A cluster-controlled clinical trial.65岁及以上人群心房颤动的机会性筛查与有症状患者检测的比较:一项整群对照临床试验。
Med Clin (Barc). 2017 Jan 6;148(1):8-15. doi: 10.1016/j.medcli.2016.07.036. Epub 2016 Oct 26.
9
Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.爱尔兰全国性心房颤动机会性筛查项目的成本效益
Value Health. 2016 Dec;19(8):985-995. doi: 10.1016/j.jval.2016.07.007. Epub 2016 Oct 5.
10
A campaign for information and diagnosis of atrial fibrillation: "pulse week".一项关于心房颤动信息宣传与诊断的活动:“脉搏周”。
Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):34-8. doi: 10.1016/j.recesp.2012.05.012. Epub 2012 Sep 8.

引用本文的文献

1
The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.心房颤动在血管性认知障碍和痴呆中的作用:流行病学、病理生理学及预防策略
Geroscience. 2025 Feb;47(1):287-300. doi: 10.1007/s11357-024-01290-1. Epub 2024 Aug 13.
2
Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable.心房颤动中风预防的障碍:全球抗凝圆桌会议的见解
Int J Cardiol Heart Vasc. 2022 Aug 1;42:101096. doi: 10.1016/j.ijcha.2022.101096. eCollection 2022 Oct.

本文引用的文献

1
Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark-The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study.丹麦全科医疗实际环境中房颤的机会性筛查——常规检测发现的房颤(AFFORD)非干预性研究
PLoS One. 2017 Nov 13;12(11):e0188086. doi: 10.1371/journal.pone.0188086. eCollection 2017.
2
Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice.在全科医疗中对老年患者进行心房颤动筛查:当前证据及其对未来实践的影响。
Eur J Gen Pract. 2017 Dec;23(1):246-253. doi: 10.1080/13814788.2017.1374366.
3
Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
阵发性和持续性心房颤动患者无症状表现状态的临床影响:伏见房颤注册研究
Chest. 2017 Dec;152(6):1266-1275. doi: 10.1016/j.chest.2017.08.004. Epub 2017 Aug 16.
4
Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.心房颤动的筛查策略:系统评价与成本效益分析
Health Technol Assess. 2017 May;21(29):1-236. doi: 10.3310/hta21290.
5
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动管理指南。
Eur J Cardiothorac Surg. 2016 Nov;50(5):e1-e88. doi: 10.1093/ejcts/ezw313. Epub 2016 Sep 23.
6
Opportunistic screening for atrial fibrillation in a rural area.农村地区心房颤动的机会性筛查。
QJM. 2016 Aug;109(8):539-543. doi: 10.1093/qjmed/hcw011. Epub 2016 Jan 27.
7
Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013).心房颤动药物治疗指南(日本循环学会2013年版)
Circ J. 2014;78(8):1997-2021. doi: 10.1253/circj.cj-66-0092. Epub 2014 Jun 26.
8
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.全球心房颤动流行病学:2010 年全球疾病负担研究。
Circulation. 2014 Feb 25;129(8):837-47. doi: 10.1161/CIRCULATIONAHA.113.005119. Epub 2013 Dec 17.
9
Screening to identify unknown atrial fibrillation. A systematic review.筛查以识别未知的心房颤动。系统评价。
Thromb Haemost. 2013 Aug;110(2):213-22. doi: 10.1160/TH13-02-0165. Epub 2013 Apr 18.
10
Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry.社区为基础的调查中房颤患者的临床背景现状:伏见房颤登记研究。
J Cardiol. 2013 Apr;61(4):260-6. doi: 10.1016/j.jjcc.2012.12.002. Epub 2013 Feb 8.